Fierce Healthcare

Tempus Picks Up CRO Highline Sciences as the Precision Medicine Company Expands Its Healthcare Ambitions

Feb 08, 2022
AI
Clinical Trials
Data
Oncology
Media Coverage

Related content

Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

2026-05-26
Oncology

A Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 Years

2025-05-28
Oncology

Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium

2024-12-10
Oncology